--- title: "PRF Technologies (PRFX) news: delisting, going concern and merger" url: "https://aibio.space/companies/prf-technologies/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "PRFX delisting, going concern and merger news: PainReform (now PRF Technologies) says Nasdaq found it compliant with Rule 5550(b)(1). PRF Technologies Ltd." --- PRFX PRF Technologies Ltd. NASDAQ · Israel # PRF Technologies (PRFX) news PRFX delisting, going concern and merger news Listings · 2026-09-03 ## [PRF Technologies reports $8,526 thousand in cash at June 30, 2026](https://aibio.space/news/prf-technologies-reports-8-526-thousand-cash-june-30-2026/) Cash rose to $8,526 thousand at June 30, 2026, from $3,125 thousand at year end, while the six-month loss was $2,942 thousand. Most of the cash came from a $10.0 million equity line that has since ended. ## Latest PRF Technologies news 1. 2026-06-18 Financings [PRF Technologies signs $15.0 million equity line with Yorkville](https://aibio.space/news/prf-technologies-signs-15-0-million-equity-line-yorkville/) The Standby Equity Purchase Agreement lets PRF sell up to $15.0 million of shares over 36 months at 97% of recent prices. Its 2026 going-concern paragraph and $3.1 million year-end cash sit beside the new line. 2. 2025-04-17 Listings [PainReform (now PRF Technologies) says Nasdaq found it compliant with Rule 5550(b)(1)](https://aibio.space/news/painreform-now-prf-technologies-says-nasdaq-found-compliant-rule-5550/) Nasdaq found PainReform complies with Rule 5550(b)(1), but warned that delisting could follow if the next periodic report does not show compliance. 3. 2025-02-18 Mergers [PainReform (now PRF Technologies) agrees to buy DeepSolar business for shares and warrants](https://aibio.space/news/painreform-now-prf-technologies-agrees-buy-deepsolar-business-shares/) The drug-delivery company is acquiring an AI solar analytics platform from BladeRanger Ltd. BladeRanger would receive 178,769 ordinary shares plus four sets of warrants, and the release gives no price or valuation for the business. ## PRF Technologies at a glance - **Ticker**: PRFX - **Listing**: NASDAQ - **Country**: Israel - **Cash, Dec 31, 2025**: $3.1 million ### Related companies - [Silexion Therapeutics](https://aibio.space/companies/silexion-therapeutics/) NASDAQ: SLXN - [Nasus Pharma](https://aibio.space/companies/nasus-pharma/) AMEX: NSRX - [Purple Biotech](https://aibio.space/companies/purple-biotech/) TASE: PPBT - [NeuroSense Therapeutics](https://aibio.space/companies/neurosense-therapeutics/) NASDAQ: NRSN - [Rekah Pharmaceutical Industry](https://aibio.space/companies/rekah-pharmaceutical-industry/) TASE: REKA - [Redhill Biopharma](https://aibio.space/companies/redhill-biopharma/) NASDAQ: RDHL - [PolyPid](https://aibio.space/companies/polypid/) NASDAQ: PYPD - [Can-Fite BioPharma](https://aibio.space/companies/can-fite-biopharma/) TASE: CANF ### Also on NASDAQ - [Seaport Therapeutics](https://aibio.space/companies/seaport-therapeutics/) SPTX - [Incannex Healthcare](https://aibio.space/companies/incannex-healthcare/) IXHL - [Beta Bionics](https://aibio.space/companies/beta-bionics/) BBNX - [Ligand Pharmaceuticals](https://aibio.space/companies/ligand-pharmaceuticals/) LGND - [Eocene](https://aibio.space/companies/eocene/) EOCN - [MetaVia](https://aibio.space/companies/metavia/) MTVA ## PRF Technologies annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$17,000](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | [$0](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | | Research and development | [$1.1 million](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | [$11.7 million](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | | Net income (loss) | [-$5.0 million](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | [-$14.6 million](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | | Cash from operations | [-$4.0 million](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | [-$12.6 million](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | | Cash and equivalents | [$3.1 million](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | [$4.3 million](https://www.sec.gov/Archives/edgar/data/1801834/000117891326001782/) | Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $3.1 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about PRF Technologies Was PRF Technologies delisted? Our latest story on this, dated Apr 17, 2025: "PainReform (now PRF Technologies) says Nasdaq found it compliant with Rule 5550(b)(1)". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/painreform-now-prf-technologies-says-nasdaq-found-compliant-rule-5550/). Has PRF Technologies issued a going-concern warning? Our latest story on this, dated Jun 18, 2026: "PRF Technologies signs $15.0 million equity line with Yorkville". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/prf-technologies-signs-15-0-million-equity-line-yorkville/). Is PRF Technologies involved in a merger or acquisition? Our latest story on this, dated Feb 18, 2025: "PainReform (now PRF Technologies) agrees to buy DeepSolar business for shares and warrants". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/painreform-now-prf-technologies-agrees-buy-deepsolar-business-shares/). What is the ticker symbol of PRF Technologies? PRF Technologies Ltd. trades under the ticker PRFX on NASDAQ. Where is PRF Technologies listed? PRF Technologies Ltd. is listed on NASDAQ. What is the SEC CIK of PRF Technologies? The SEC Central Index Key (CIK) for PRF Technologies Ltd. is 1801834. Its filings are on SEC EDGAR. How many shares does PRF Technologies have outstanding? 830,613 shares as of 2025-12-31, per the cover page of its 20-F filed 2026-03-26. Which country or territory is PRF Technologies listed under? Our directory records PRF Technologies Ltd. under Israel. What does PRF Technologies do? Our directory classifies PRF Technologies Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of PRF Technologies? The ISIN recorded for PRF Technologies Ltd. is IL0011651580. Does aibio.space cover PRF Technologies? aibio.space lists PRF Technologies Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Where is PRF Technologies incorporated? SEC records list its state or country of incorporation as L3. What was PRF Technologies's revenue last year? $17,000 for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is PRF Technologies profitable? PRF Technologies Ltd. reported a net loss of $5.0 million for the fiscal year ended Dec 31, 2025, and used $4.0 million of cash in operations, per its annual report to the SEC. How much does PRF Technologies spend on research and development? $1.1 million in the fiscal year ended Dec 31, 2025, per its annual report. ## Investor discussion: PRF Technologies Members talk about PRF Technologies (PRFX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at PRF Technologies, newest first. Each line links the filing it comes from. 1. 2026-09-03 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891326004401/exhibit_99-1.htm) 2. 2026-06-18 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891326003263/zk2635551.htm) 3. 2026-02-03 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891326000291/zk2634278.htm) 4. 2026-01-05 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891326000040/exhibit_99-1.htm) 5. 2025-11-25 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891325003957/exhibit_99-1.htm) 6. 2025-04-17 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891325001323/zk2533030.htm) 7. 2025-04-11 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891325001284/zk2533010.htm) 8. 2025-04-07 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891325001223/exhibit_99-1.htm) 9. 2025-02-18 Mergers Reported a merger or acquisition agreement. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891325000522/exhibit_99-1.htm) 10. 2024-12-04 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891324003910/zk2432426.htm) 11. 2024-11-18 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891324003751/zk2432345.htm) 12. 2024-11-07 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1801834/000117891324003541/exhibit_99-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:PRFX on TradingView](https://www.tradingview.com/symbols/NASDAQ-PRFX/). ## SEC filings and registration - **SEC name**: PRF Technologies Ltd. - **CIK**: 1801834 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: PRFX (Nasdaq) - **State or country of incorporation**: L3 - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer - **Business address**: 65 YIGAL ALON ST., TEL AVIV - **Phone**: 972-3-7177051 - **Shares outstanding**: 830,613 as of 2025-12-31 (20-F filed 2026-03-26) - **Former names**: PAINREFORM LTD. ### Recent filings (8-K and 6-K are the company's own announcements) - [6-K](https://www.sec.gov/Archives/edgar/data/1801834/000117891326004625/zk2636164.htm) filed 2026-09-28 - [6-K](https://www.sec.gov/Archives/edgar/data/1801834/000117891326004526/zk2636122.htm) filed 2026-09-16 - [6-K](https://www.sec.gov/Archives/edgar/data/1801834/000117891326004455/zk2636092.htm) filed 2026-09-09 - [6-K](https://www.sec.gov/Archives/edgar/data/1801834/000117891326004401/zk2635991.htm) filed 2026-09-03 - [6-K](https://www.sec.gov/Archives/edgar/data/1801834/000117891326003581/zk2635724.htm) filed 2026-07-27 - [6-K](https://www.sec.gov/Archives/edgar/data/1801834/000117891326003546/zk2635713.htm) filed 2026-07-21 - [6-K](https://www.sec.gov/Archives/edgar/data/1801834/000117891326003494/zk2635687.htm) filed 2026-07-15 - [6-K](https://www.sec.gov/Archives/edgar/data/1801834/000117891326003444/zk2635658.htm) filed 2026-07-08 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001801834), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details PRF Technologies Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PRFX, recorded under Israel. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: PRF Technologies Ltd. - **Ticker**: PRFX - **Listing**: NASDAQ - **Country or territory**: Israel - **Business scope**: Pharmaceuticals: Major - **ISIN**: IL0011651580 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-PRFX/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/prf-technologies/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "PRF Technologies (PRFX) news: delisting, going concern and merger", 2026-10-31, https://aibio.space/companies/prf-technologies/